CMIT signs six-year contract with Eli Lilly/AVID for PET radiopharmaceutical

CMIT has signed a six-year contract with Eli Lilly/AVID to produce F-18 labeled AV-1451 PET radiopharmaceutical for early detection of Alzheimer's disease at its Southern Isotopes facility in Shreveport.

“CMIT has signed a six-year contract with Eli Lilly/ AVID to produce a PET radiopharmaceutical for early detection of Alzheimer’s disease.”brfla.org

• 1 source
• brfla.orgCMIT manufactures PET radiopharmaceuticals to detect neurodegenerative diseases - BRFCourtney BryanJun 13, 2018

Summarized from public sources; check the original articles before acting on it.